Literature DB >> 871809

Convulsive seizures and viloxazine.

J G Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 871809      PMCID： PMC1630945          DOI： 10.1136/bmj.2.6079.96-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent.

Authors:  K B Mallion; A H Todd; R W Turner; J G Bainbridge; D T Greenwood; J Madinaveitia; A R Somerville; B A Whittle
Journal:  Nature       Date:  1972-07-21       Impact factor: 49.962

2.  Valium: a discussion of current issues.

Authors:  L E Hollister
Journal:  Psychosomatics       Date:  1977       Impact factor: 2.386

3.  [Doubleblind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients (author's transl)].

Authors:  L Floru; G Czarny; J Tegeler
Journal:  Arzneimittelforschung       Date:  1976
  3 in total
  5 in total

Review 1.  Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy.

Authors:  B Blackwell
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

2.  Does viloxazine have epileptogenic properties?

Authors:  J G Edwards; M Glen-Bott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

3.  Mianserin and convulsive seizures.

Authors:  J G Edwards; M Glen-Bott
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon.

Authors:  B S Meldrum; G M Anlezark; H K Adam; D T Greenwood
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  Seizures following the withdrawal of long-term treatment with mianserin.

Authors:  D De Leo; G Dalla Barba; G Zanchin
Journal:  Ital J Neurol Sci       Date:  1988-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.